Ann: Sensera completes A$2.5m private placement, page-189

This link has been posted previously but... https://www.cdc.gov/csels/dls/locs/...-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html

A couple of excerpts..

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.

CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses

Now.. What would be the result here, if BioDirection's NanoDx was the next big thing in testing, adopted from 31st December onwards??

Ahh but just give me the EUA for the single test and I'll be happy!